novo nordisk fda semaglutide approves higher-dose Wegovy to help people lose more weight A New Era of Weight

Patients who have experienced NAION while using GLP-1 medications may have legal options

They want compounds that preserve muscle during weight loss

Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist originally developed for type 2 diabetes that was subsequently found to produce substantial weight loss

A peerreviewed summary of the STEP program provides event estimates and context for clinicians and patients making riskbenefit decisions

If it feels slower than expected, thats often part of the normal adjustment process, not a sign that the medication isnt working

An important note is that you should not store the pills in a pill organizer box keep them in the blue-capped bottle until youre ready to take them